Pre-exposure prophylaxis (PrEP) is a novel biomedical intervention that is highly effective in reducing HIV infections. PrEP is taken as a daily pill or in an on-demand regimen at times when a high risk of HIV is expected. Despite the high effectiveness of PrEP, the uptake of PrEP has been limited in the past years, because PrEP was limited accessible and expensive. This PhD project investigated how men who have sex with men (MSM) obtained PrEP in the years before PrEP became available (and affordable) in pharmacies in the Netherlands in 2017. Furthermore, this research investigated hurdles for PrEP use in the Netherlands and the sexual behaviour of PrEP users after PrEP initiation.
|Award date||31 Mar 2021|
|Place of Publication||Maastricht|
|Publication status||Published - 2021|
- HIV prevention
- sexual behaviour
- risk perception